It was just announced that 454 Life Sciences, a Roche subsidiary, has partnered with DNA Electronics to develop a low-cost, high-throughput, long-read, high-density DNA sequencing system. Looking to build on its current pyrosequencing-based platform, 454 has tapped DNA Electronics to provide IP from its proprietary semiconductor technology portfolio. The goal of the collaboration is to produce a "seamless evolution from optical detection to low-cost, highly scalable electrochemical detection."
"We have always believed that the marriage between mature standard CMOS semiconductor technology, ubiquitous in the consumer electronics world, and the molecular life science industry will eventually transform research machines into affordable diagnostics tools," said Christopher Toumazou, DNA Electronics chairman and CEO, in a statement.
DNA ...